Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Erythrocyte Adherence to Endothelium in Sickle-Cell Anemia
Citations per year, relative to Marc Boogaerts Marc Boogaerts (= 1×)
peers
M. Boogaerts
Countries citing papers authored by Marc Boogaerts
Since
Specialization
Citations
This map shows the geographic impact of Marc Boogaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Boogaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Boogaerts more than expected).
This network shows the impact of papers produced by Marc Boogaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Boogaerts. The network helps show where Marc Boogaerts may publish in the future.
Co-authorship network of co-authors of Marc Boogaerts
This figure shows the co-authorship network connecting the top 25 collaborators of Marc Boogaerts.
A scholar is included among the top collaborators of Marc Boogaerts based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Marc Boogaerts. Marc Boogaerts is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Meers, Stef, Peter Vandenberghe, Marc Boogaerts, et al.. (2008). 5-aza-2 '-deoxycytidine can induce differentiation of clonal abnormal progenitor cells from patients with myelodysplastic syndromes without induction of apoptosis. Haematologica. 93. 91–91.4 indexed citations
3.
Raeymaekers, Luc, et al.. (2007). Apoptosis levels of CD34+cells after induced DNA damage: Measurement of DNA fragmentation in different annexin V-affinity fractions of sorted CD34+cells using the DNA diffusion assay and comet assay. Acta Clinica Belgica. 62(4). 264–264.1 indexed citations
4.
Janssens, Stefan, Jan Bogaert, Koen Theunissen, et al.. (2005). Transplantation of autologous bone marrow-derived stem cells in patients with ST-segment elevation myocardial infarction. Circulation. 112(17).
Delforge, Michel, et al.. (2000). Reduced expression of alpha 5 beta 1 integrins on CD34(+) marrow progenitors of MDS patients with high levels of apoptosis. Blood. 96(11).1 indexed citations
7.
Maertens, Johan & Marc Boogaerts. (1999). Antifungal prophylaxis in neutropenia. Current Opinion in Infectious Diseases. 12(6). 549–555.3 indexed citations
8.
Boogaerts, Marc, Gary Garber, D. J. Winston, et al.. (1999). Itraconazole (IT) compared with amphotericin B (AMB) as empirical therapy for persistent fever of unknown origin (FUO) in neutropenic patients (PTS). Bone Marrow Transplantation. 23.9 indexed citations
9.
Vandenberghe, Peter, H Demuynck, Gregor Verhoef, et al.. (1998). Intensive non-myeloablative chemotherapy can induce GvHD and complete remission in patients with AML/MDS relapsing after allo-BMT. British Journal of Haematology. 102(1). 210–210.1 indexed citations
10.
Meeus, Peter, et al.. (1998). Application of the international scoring system (IPSS) for myelodysplastic syndromes (MDS). Blood. 92(10).1 indexed citations
11.
Maertens, J., H Demuynck, Gregor Verhoef, et al.. (1996). Granulocyte-macrophage colony-stimulating factor (GM-CSF) fails to improve outcome in invasive fungal infections in neutropenic cancer patients. Blood. 88(10). 3274–3274.1 indexed citations
12.
Włodarska, Iwona, Licia Selleri, Caroline Paternotte, et al.. (1996). FISH characterization of two new meyloid breakpoints in t(11;21)(q24;q11.2) translocaton associated wit Myelodysplastic Syndromes (MDS). British Journal of Haematology. 93. 161–161.2 indexed citations
13.
Stroobants, Sigrid, Patrick Dupont, Gregor Verhoef, et al.. (1996). Comparison of whole-body positron emission tomography and Gallium-67 citrate imaging for staging of lymphoma. Blood. 88(10). 901–901.2 indexed citations
14.
Demuynck, H, Gregor Verhoef, Johan Maertens, et al.. (1996). Intensive chemotherapy followed by autologous progenitor cell transplantation may lead to prolonged hematological and molecular remission in chronic lymphocytic leukemia (CLL). Blood. 88(10). 488–488.1 indexed citations
Kluin‐Nelemans, Hanneke C., André Delannoy, Marc Boogaerts, et al.. (1995). CML treated by low dose interferon alfa-2B vs hydroxyurea alone: interim report of a multicenter randomized trial. Blood. 86.1 indexed citations
Hoof, Ambro van, et al.. (1982). Bone marrow transplantation in a patient with secondary leukemia. Experimental Hematology. 10. 83–83.24 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.